Advertisement feature Bioclad Ltd patent awarded
Bioclad Ltd, based in Harrogate, is a leading provider of hygienic solutions, with products installed in healthcare, pharmaceutical, education, and leisure facilities worldwide. The company’s expansive portfolio includes bespoke Integrated Plumbing Systems (IPS), Antimicrobial PVC Cladding, Wall Protection Systems, and decorative PVC finishes. Supported by its in-house installation team, Advanced Hygienic Contracting, along with a trusted UK-wide installer network and an expanding network of international partners, Bioclad continues to set the standard for hygienic innovation.
In 2025, Bioclad was officially granted a patent for its bespoke antimicrobial IPS units. Originally launched in 2017, the Biopod was the world’s first antimicrobial IPS unit, marking a breakthrough in infection prevention. With this patent, Bioclad now holds the exclusive rights as the sole manufacturer of antimicrobial IPS units – solidifying its position at the forefront of hygiene technology.
Receiving the patent award for our bespoke antimicrobial IPS units is a significant milestone for Bioclad – one that reinforces our position as pioneers in hygienic innovation. This recognition not only validates years of dedicated research, development, and product refinement, but also sets a new benchmark within the healthcare interiors industry. Holding the exclusive rights to manufacture antimicrobial IPS units gives us a unique opportunity to lead the way in infection control solutions, offering clients assurance of quality, compliance, and innovation they can trust. More broadly, this achievement raises the standard across the sector,
CASE STUDY: BIOCLAD® The challenge of microbial growth
Industries operating in public and healthcare environments require high- performance, hygienic surfaces that can withstand rigorous use. Polyvinyl Chloride (PVC) is widely used in the healthcare, construction, and transport industries for its durability, corrosion resistance, chemical stability, and cost- effectiveness. However, PVC is vulnerable to microbial colonisation, leading to odours, staining, and material degradation over time. It can also emits volatile organic compounds (VOCs), especially under thermal or UV stress.
BioClad® BioClad®
and BioCote® Antimicrobial Solutions
offers a range of antimicrobial solutions – including wall cladding and BioPods – that integrate BioCote® for long-lasting protection. Working with BioCote®
antimicrobial technology ensures thorough and
optimal integration of antimicrobial technologies in manufacturing, offering permanent protection against microbes that compromise PVC quality and durability.
This built-in protection provides: • Continuous defence against bacteria, mould, and yeast growth.
T: 01423 647055 E:
sophie.warhurst@bioclad.com
Bioclad Limited, Unit 7 Bardner Bank, Burley Road, Killinghall HG3 2FN
encouraging continued investment in antimicrobial technologies, and pushing the industry toward safer, smarter, and more sustainable design practices. At Bioclad, our passion lies in creating hygienic solutions that are not only safe and functional, but also built to stand the test of time. We are deeply committed to delivering products that enhance both patient and staff safety, which is why every unit we design undergoes meticulous in-house development.
From integrating reinforced corners specifically engineered for high- risk mental health environments, to designing seamless access panels that maintain a clean, tamper-proof finish, every detail is purposefully crafted with end-user safety in mind.
Our drive for excellence is rooted in the belief that antimicrobial technology represents the most effective, reliable defence against harmful pathogens in clinical settings. By embedding antimicrobial protection directly into our products at the first stages of manufacturing, we ensure long-lasting
ANTIMICROBIAL PVC SOLUTIONS WITH BIOCOTE®
• Reduced risk of staining, odours, and material degradation. • Lower maintenance requirements and long-term cost savings. • Extended product lifespan, making BioClad®
BioCote® To assess the long-term performance of BioClad® a smart investment. independent third-party testing was commissioned by BioClad®
Antimicrobial Technology: Tested, Effective, Trusted antimicrobial cladding, . Samples
from BioClad® and several market-leading cladding brands were submitted and tested to the ISO 22196 standard for antibacterial efficacy. Before testing, all samples underwent an accelerated ageing process:
1128 hours at 65 °C in dry heat. This process is essential to remove VOCs such as hydrochloric acid (HCl), which are naturally released from freshly manufactured PVC. Without ageing, test results can be skewed, as bacteria may be reduced by these short-lived chemicals rather than the antimicrobial additive itself. Ageing ensures the test reflects how a product will perform in real-life environments over time.
Each sample was then tested against MRSA and E. coli, two bacteria commonly found in healthcare and hygiene-critical settings. Table 1
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
